Stock Alert: Co-Diagnostics Gains After Its Covid-19 Test Gets EUA
Published
Shares of Co-Diagnostics, Inc. (CODX) are climbing more than 20% Monday morning after the molecular diagnostics company announced that its Logix Smart Coronavirus COVID-19 Test has obtained Emergency Use Authorization (EUA) from the FDA to be used for the diagnosis of SARS-CoV-2.
Full Article